HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease.

AbstractPURPOSE:
Graft versus host disease (GVHD) is the major complication of allogeneic bone marrow transplantation (BMT) and limits the therapeutic efficacy of this modality. Although the role of natural T-regulatory cells (nTreg) in attenuating GVHD has been extensively examined, the ability of induced T-regulatory cells (iTreg) to mitigate GVHD is unknown. The purpose of this study was to examine the ability of in vitro and in vivo iTregs to abrogate GVHD.
EXPERIMENTAL DESIGN:
We examined the ability of in vitro differentiated and in vivo iTregs to reduce the severity of GVHD in a clinically relevant mouse model of BMT. The effect of blockade of interleukin (IL) 6 signaling on the efficacy of these Treg populations was also studied.
RESULTS:
In vitro differentiated iTregs fail to protect mice from lethal GVHD even when administered at high Treg:effector T-cell ratios. Lack of GVHD protection was associated with loss of Foxp3 expression and in vivo reversion of these cells to a proinflammatory phenotype characterized by secretion of IFN-γ. Phenotypic reversion could not be abrogated by blockade of IL-6 signaling or by in vitro exposure of iTregs to all-trans retinoic acid. In contrast, the in vivo induction of iTregs was significantly augmented by IL-6 blockade and this resulted in reduced GVHD.
CONCLUSION:
Instability of Foxp3 expression limits the utility of adoptively transferred iTregs as a source of cellular therapy for the abrogation of GVHD. Blockade of IL-6 signaling augments the ability of in vivo iTregs to prevent GVHD but has no effect on in vitro differentiated iTregs.
AuthorsAmy Beres, Richard Komorowski, Masahiko Mihara, William R Drobyski
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 17 Issue 12 Pg. 3969-83 (Jun 15 2011) ISSN: 1557-3265 [Electronic] United States
PMID21558402 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2011 AACR.
Chemical References
  • Antibodies, Blocking
  • Forkhead Transcription Factors
  • Foxp3 protein, mouse
  • Immunologic Factors
  • Receptors, Interleukin-6
  • Tretinoin
Topics
  • Animals
  • Antibodies, Blocking (immunology, pharmacology)
  • Bone Marrow Transplantation (adverse effects)
  • Forkhead Transcription Factors (genetics, metabolism)
  • Gene Expression Regulation (immunology)
  • Graft vs Host Disease (etiology, genetics, immunology, physiopathology)
  • Immunologic Factors (immunology, pharmacology)
  • Inflammation (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Phenotype
  • Receptors, Interleukin-6 (antagonists & inhibitors, immunology)
  • Signal Transduction (drug effects, immunology)
  • T-Lymphocytes, Regulatory (drug effects, immunology)
  • Tretinoin (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: